Progressive Supranuclear Palsy

The PROSPER Study aims to assess how safe and effective a study medicine called FNP223 may be in treating progressive supra-nuclear palsy (PSP).

You may be able to join the PROSPER Study if you:

• Are between 50 and 80 years old
• Have been told by your doctor that you possibly or probably have PSP of Richardson’syndrome subtype
• Started experiencing PSP symptoms within the last 3 years
• Can walk independently or with a cane (at least 10 steps)
• Have a caregiver or study partner who can accompany you to study visits